GlassScriptPhysician profile
Lynn A Dana
NPI 1164844874
$4,303.89
in general payments reported to CMS, 2019-2025
16 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,737 · 2022: $879 · 2023: $918 · 2024: $395 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,688.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,480.42 | 2021-2024 | |
| Forte Bio-Pharma LLC | $1,452.62 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Lundbeck LLC | $268.71 | 2021-2023 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $255.94 | 2021-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $218.38 | 2021-2024 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $196.44 | 2021-2024 | Caplyta |
| Neos Therapeutics, LP | $107.15 | 2021-2023 | Adzenys Xr-Odt |
| Lilly USA, LLC | $63.02 | 2022 | |
| Axsome Therapeutics, INC. | $47.61 | 2023-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $42.14 | 2021 | |
| Corium, LLC | $40.44 | 2023 | Azstarys |
| Merck Sharp & Dohme LLC | $35.50 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $31.54 | 2022 | |
| Supernus Pharmaceuticals, INC. | $24.03 | 2022 | |
| Biogen, INC. | $22.35 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $17.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Dana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.